John L. Cleveland
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
John L. Cleveland has a total of 403 co-authors. Here are the top co-authors by number of shared publications:
- Anders E. Berglund
Department of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, 4500 San Pablo Road South, Jacksonville, FL 32224, USA
68 shared publications - Ariosto Siqueira Silva
Department of Metabolism and Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA
58 shared publications - Jamie K. Teer
Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
58 shared publications - Praneeth Reddy Sudalagunta
Department of Metabolism and Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA
57 shared publications - Rafael Renatino Canevarolo
Department of Metabolism and Physiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA
56 shared publications - Robert A. Gatenby
Moffitt Cancer Center
56 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Figure S23 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Differential gene accessibility and expression across LRMM_5 subclusters.
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S23 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Differential gene accessibility and expression across LRMM_5 subclusters.
- Open Access
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Figure S24 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Copy number variation inferred by inferCNV on single cell gene expression from scMultiome data.
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S24 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Copy number variation inferred by inferCNV on single cell gene expression from scMultiome data.
- Open Access
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Figure S25 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
SE-associated genes per sample.
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S25 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
SE-associated genes per sample.
- Open Access
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Figure S26 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Differential lethality and therapeutic target candidates in MM.
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S26 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Differential lethality and therapeutic target candidates in MM.
- Open Access
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Figure S27 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Within-cell line analysis of YY1 silencing on proliferation and drug resistance.
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S27 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Within-cell line analysis of YY1 silencing on proliferation and drug resistance.
- Open Access
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Figure S28 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
NSD2 expression dynamics in relation to t(4;14) status and disease stage.
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S28 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
NSD2 expression dynamics in relation to t(4;14) status and disease stage.
- Open Access
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Association between UAMS subgroups and PCA quadrants.
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Association between UAMS subgroups and PCA quadrants.
- Open Access
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Forest plots from multivariate Cox proportional hazard models showing significant features.
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Forest plots from multivariate Cox proportional hazard models showing significant features.
- Open Access
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Transcriptomic profile bears prognostic value in an independent cohort of MM patients.
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Transcriptomic profile bears prognostic value in an independent cohort of MM patients.
- Open Access
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Transcriptional changes in longitudinal samples.
- 15 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma
Transcriptional changes in longitudinal samples.